The U.S. Food and Drug Administration’s (FDA) vaccine advisors recommended the Novavax COVID-19 vaccine for emergency use authorization on Tuesday, paving the way for a fourth U.S. vaccine. The panel’s vote was 21 in favor of authorizing Novavax and one abstention. However, FDA authorization could be delayed because the company informed the agency just four […]